HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Martin Dreyling Selected Research

Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)

1/2022Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial.
7/2021Rituximab Maintenance Versus Observation After Immunochemotherapy (R-CHOP, R-MCP, and R-FCM) in Untreated Follicular Lymphoma Patients: A Randomized Trial of the Ostdeutsche Studiengruppe Hämatologie und Onkologie and the German Low-Grade Lymphoma Study Group.
6/2020Final Results of a Phase I/II Trial of the Combination Bendamustine and Rituximab With Temsirolimus (BeRT) in Relapsed Mantle Cell Lymphoma and Follicular Lymphoma.
1/2020HOVON110/ReBeL Study: Results of the Phase I Part of a Randomized Phase I/II Study of Lenalidomide, Rituximab With or Without Bendamustine in Patients With Relapsed/Refractory Follicular Lymphoma.
1/2020Evaluating upfront high-dose consolidation after R-CHOP for follicular lymphoma by clinical and genetic risk models.
8/2019Therapy of nodal Follicular Lymphoma (WHO grade 1/2) in clinical stage I/II using response adapted Involved Site Radiotherapy in combination with Obinutuzumab (Gazyvaro) - GAZAI Trial (GAZyvaro and response adapted Involved-site Radiotherapy): a study protocol for a single-arm, non-randomized, open, national, multi-center phase II trial.
5/2019Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (ROMULUS).
12/2018Rituximab With Involved Field Irradiation for Early-stage Nodal Follicular Lymphoma: Results of the MIR Study.
1/2018[Malignant B-Cell Lymphoma: Advances in the Therapy of Follicular Lymphoma and Mantle-cell Lymphoma].
1/2018Autologous Stem Cell Transplantation for Patients with Early Progression of Follicular Lymphoma: A Follow-Up Study of 2 Randomized Trials from the German Low Grade Lymphoma Study Group.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Martin Dreyling Research Topics

Disease

83Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
10/2022 - 01/2003
59Lymphoma (Lymphomas)
07/2022 - 01/2003
39Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2022 - 01/2003
29Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2022 - 01/2003
27Neoplasms (Cancer)
05/2021 - 01/2005
20B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 04/2006
18Disease Progression
01/2022 - 06/2003
13Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
07/2022 - 04/2006
13B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2020 - 09/2004
11Genetic Translocation (Chromosomal Translocation)
01/2017 - 01/2009
5Infections
01/2021 - 02/2009
4Neutropenia
12/2021 - 03/2014
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 07/2003
4Residual Neoplasm
01/2018 - 03/2006
3Hyperglycemia
11/2021 - 01/2019
3Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2021 - 09/2010
3Diarrhea
01/2019 - 03/2014
3Hodgkin Disease (Hodgkin's Disease)
01/2016 - 04/2006
2T-Cell Lymphoma (Lymphoma, T Cell)
01/2022 - 09/2010
2Cytokine Release Syndrome
12/2021 - 06/2015
2Inflammation (Inflammations)
12/2021 - 10/2018
2Nausea
11/2021 - 07/2014
2Hypertension (High Blood Pressure)
11/2021 - 01/2019
2Hemorrhage
01/2019 - 08/2015
2Pneumonia (Pneumonitis)
01/2019 - 03/2014
2Multiple Myeloma
01/2016 - 02/2010
2Chromosome Aberrations (Chromosome Abnormalities)
03/2012 - 02/2009
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
07/2011 - 12/2007
2Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
09/2010 - 03/2010
1Orbital lymphoma
07/2022

Drug/Important Bio-Agent (IBA)

47Rituximab (Mabthera)FDA Link
01/2022 - 01/2003
18Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2022 - 01/2003
18Bendamustine HydrochlorideFDA Link
01/2022 - 07/2007
14ibrutinibIBA
10/2022 - 08/2013
14Vincristine (Oncovin)FDA LinkGeneric
01/2022 - 12/2004
14Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 12/2004
14Cyclin D1IBA
01/2017 - 10/2008
12Monoclonal AntibodiesIBA
01/2021 - 11/2004
11Prednisone (Sone)FDA LinkGeneric
01/2022 - 12/2004
10Cytarabine (Cytosar-U)FDA LinkGeneric
01/2022 - 05/2009
9Proteins (Proteins, Gene)FDA Link
10/2021 - 11/2006
9Biological ProductsIBA
10/2019 - 04/2006
8Agammaglobulinaemia Tyrosine KinaseIBA
10/2022 - 08/2013
8Biomarkers (Surrogate Marker)IBA
12/2021 - 08/2007
8fludarabineIBA
01/2021 - 01/2003
8Bortezomib (Velcade)FDA Link
07/2015 - 06/2003
7Lenalidomide (CC 5013)FDA Link
01/2021 - 09/2008
7temsirolimusFDA Link
06/2020 - 06/2013
6AntibodiesIBA
07/2021 - 06/2003
5Chimeric Antigen ReceptorsIBA
07/2022 - 11/2019
5copanlisibIBA
11/2021 - 12/2017
5AntigensIBA
05/2021 - 01/2007
5Pharmaceutical PreparationsIBA
01/2021 - 02/2007
5Mitoxantrone (Novantrone)FDA LinkGeneric
07/2007 - 01/2003
4tisagenlecleucelIBA
07/2022 - 12/2021
4DNA (Deoxyribonucleic Acid)IBA
09/2015 - 09/2009
4Proteasome InhibitorsIBA
06/2012 - 09/2008
3axicabtagene ciloleucelIBA
07/2022 - 01/2021
3Dexamethasone (Maxidex)FDA LinkGeneric
01/2022 - 08/2016
3CytokinesIBA
12/2021 - 10/2018
3Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
11/2021 - 12/2017
3Interferon-alpha (Interferon Alfa)IBA
09/2021 - 11/2004
3purineIBA
01/2021 - 09/2004
3tafasitamabIBA
01/2021 - 01/2020
3obinutuzumabIBA
08/2019 - 02/2015
3idelalisibIBA
04/2016 - 03/2014
3Alkylating AgentsIBA
01/2015 - 02/2010
2Cisplatin (Platino)FDA LinkGeneric
01/2022 - 08/2016
2TOR Serine-Threonine KinasesIBA
11/2021 - 09/2008
2AutoantigensIBA
10/2021 - 10/2008
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
07/2021 - 01/2021
2Complement System Proteins (Complement)IBA
07/2021 - 01/2005
2Etoposide (VP 16)FDA LinkGeneric
04/2021 - 01/2021
2Prednisolone (Predate)FDA LinkGeneric
04/2021 - 06/2014
2LigandsIBA
10/2019 - 01/2015
2Protein Isoforms (Isoforms)IBA
01/2019 - 12/2017
2B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA
10/2017 - 01/2016
2Proteasome Endopeptidase Complex (Proteasome)IBA
12/2014 - 03/2009
2enzastaurinIBA
07/2014 - 02/2010
2Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
05/2014 - 11/2009
2Chlorambucil (Leukeran)FDA Link
03/2011 - 09/2006
2Alemtuzumab (Campath)FDA Link
03/2010 - 01/2005
2Radioisotopes (Radionuclides)IBA
01/2009 - 01/2005
2ProteomeIBA
12/2007 - 11/2006
2ibritumomab tiuxetan (Zevalin)FDA Link
08/2006 - 01/2005
1GemcitabineFDA Link
01/2022

Therapy/Procedure

64Therapeutics
10/2022 - 06/2003
36Drug Therapy (Chemotherapy)
10/2022 - 01/2003
19Stem Cell Transplantation
09/2021 - 11/2004
8Salvage Therapy
01/2020 - 04/2006
6Radiotherapy
07/2022 - 05/2013
5Transplantation
01/2021 - 07/2005
5Chemoradiotherapy
08/2016 - 11/2004
4Radioimmunotherapy
12/2011 - 07/2005
3Cell Transplantation
12/2021 - 05/2019
2Induction Chemotherapy
01/2022 - 01/2019
2Time-to-Treatment
01/2018 - 03/2005
2Precision Medicine
08/2015 - 06/2015
2Homologous Transplantation
03/2015 - 07/2005
2Immunotherapy
10/2008 - 07/2007